Skip to content

ANNAMARIA RUZZO

  • BSc, PhD
  • Molecular Biologist
  • University of Urbino Carlo Bo
  • 27h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2906CitationsNumber of citations received by ANNAMARIA's publications. Updated daily.

Research interests

pharmacogenetics

Co-authors (259)

  • Elisa Carloni
  • Sara  Piselli
  • Francesca Buccino
  • Irene Bagaloni
  • Francesca Andreoni

Publications (5)

  • Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

    • Ruzzo A
    • Graziano F
    • Galli F
    N/AReaders
    N/ACitations
    Get full text
  • MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine

    • Visani G
    • Loscocco F
    • Ruzzo A
    N/AReaders
    N/ACitations
    Get full text
  • KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    • Loupakis F
    • Ruzzo A
    • Cremolini C
    N/AReaders
    368Citations
    Get full text
  • High concordance of KRAS status between primary colorectal tumors and related metastatic sites: Implications for clinical practice

    • Santini D
    • Loupakis F
    • Vincenzi B
    N/AReaders
    177Citations
    Get full text
  • Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer

    • Graziano F
    • Ruzzo A
    • Loupakis F
    N/AReaders
    97Citations
    Get full text

Professional experience

Molecular Biologist

Universita degli Studi di Urbino Carlo Bo

September 1990 - Present

Education history

PhD

Università degli Studi di Urbino Carlo Bo

October 2002 - February 2006(3 years)

Biological Sciences

University of Urbino School of Biological Sciences

October 1982 - June 1986(4 years)